Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bebtelovimab
Pharma
FDA pulls Eli Lilly's COVID-19 antibody bebtelovimab
The FDA revoked its emergency use authorization for Eli Lilly's bebtelovimab because the antibody can't neutralize certain omicron subvariants.
Zoey Becker
Dec 1, 2022 10:15am
For $275M, Lilly to provide more COVID antibody doses to US
Jun 29, 2022 11:00am
Paxlovid usage is ticking up in the US
May 26, 2022 10:40am
Lilly wins FDA approval for yet another COVID-19 antibody drug
Feb 11, 2022 5:42pm
